Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05902286 · ClinicalTrials.gov registry record · Early Phase 1
Heart Rate Variability Biofeedback in Older Adults
A Early Phase 1 study of Older Adult, sponsored by Brigham Young University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT05902286: Completed Early Phase 1 study of Older Adult, sponsored by Brigham Young University.
NCT05902286 is a Early Phase 1 study of Older Adult that has completed, run by Brigham Young University. The registered enrollment target is 59 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05902286, a Early Phase 1 study of Older Adult, has completed, sponsored by Brigham Young University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
Older adults will be randomly assigned to an active heart rate variability biofeedback condition and a "sham" control condition. Stress recovery measures and emotional and cognitive functioning will be assessed before and following the five-week intervention to assess potential changes from the intervention.
Primary Outcome
The first primary aim of the paper is to test whether there will be difference resting HRV measurements pre- to post-intervention.
Conditions Studied
Interventions
- BEHAVIORAL OSC+
- BEHAVIORAL OSC-
Study Locations (1)
Utah
- Brigham Young Unversity - Provo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2024-05-22 |
| Phase | Early Phase 1 |
What the finished NCT05902286 record still lists
NCT05902286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Older Adult appearing as the primary indexed condition, and to 2 interventions - of which OSC+ is the first listed.
NCT05902286 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05902286 about?
NCT05902286 is a clinical study titled "Heart Rate Variability Biofeedback in Older Adults". Older adults will be randomly assigned to an active heart rate variability biofeedback condition and a "sham" control condition. Stress recovery measures and emotional and cognitive functioning will be assessed before and following the five-week intervention to assess potential changes from the inte...
What is the current status of trial NCT05902286?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 59 participants. The study started on 2023-02-17. Estimated completion is 2024-05-22.
What conditions does trial NCT05902286 study?
This clinical trial studies the following conditions: Older Adult.
What interventions are being tested in trial NCT05902286?
The interventions under investigation include: OSC+ (BEHAVIORAL), OSC- (BEHAVIORAL).
Who is sponsoring clinical trial NCT05902286?
This trial is sponsored by Brigham Young University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05902286 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Older Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05902286's enrollment target sits among peer trials
59 437th of 2000 higher than 1,561 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI